ALT and AST: why liver enzymes run high and when to retest

ALT and AST are liver enzymes that often run mildly elevated for benign, reversible reasons: alcohol, recent intense exercise, certain medications, viral illness, and metabolic dysfunction-associated steatotic liver disease. Clinicians typically retest after 2 to 6 weeks once the likely trigger is removed, and investigate further if levels stay up or climb.

Open almost any routine blood panel and you'll find ALT and AST sitting near the top of the liver section. When one or both come back high, the reflex is to assume the worst — but mild elevations are common, often transient, and frequently tied to something as mundane as a hard workout the day before the draw.

Here's what these two enzymes actually measure, what tends to push them up, and when a clinician circles back for a repeat test.

What ALT and AST actually are — in plain English

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are enzymes that live inside cells. ALT is concentrated in the liver. AST is in the liver too, but also in skeletal muscle, heart, red blood cells, and kidney.

When those cells are stressed or damaged, the enzymes leak into the bloodstream. A high number on a lab report is really a measure of how much has leaked, not a direct read of liver function.

That distinction matters. ALT is the more liver-specific of the two. AST can rise for reasons that have nothing to do with the liver at all — which is why clinicians look at the pattern, not just the single value.

Reference ranges vary by lab, but most adult upper limits sit around 30-40 U/L for ALT and 35-40 U/L for AST. The ACG guideline on abnormal liver chemistries argues the true healthy upper limit for ALT is probably lower than most labs report, closer to 29-33 U/L in men and 19-25 U/L in women.

The common reasons they run high — what actually moves the number

Most mild elevations (under about 5x the upper limit) trace back to a short list of causes.

Metabolic dysfunction-associated steatotic liver disease (MASLD). Formerly called NAFLD, this is now the most common cause of chronically elevated ALT in adults in the United States. It's tied to insulin resistance, central adiposity, and the metabolic syndrome cluster. The AASLD 2023 guidance treats persistently elevated ALT in someone with cardiometabolic risk factors as MASLD until proven otherwise.

Alcohol. Even moderate intake in the days before a draw can nudge AST up. A classic clue is an AST:ALT ratio above 2, though the ratio is suggestive, not diagnostic.

Recent intense exercise. This one surprises people. A 2008 study in otherwise healthy men showed that eccentric strength training could push AST and ALT into ranges that look alarming for days afterward — AST more than ALT, because muscle is a major AST source. If you lifted hard or ran long in the 72 hours before the draw, that's often the entire story.

Medications and supplements. Acetaminophen at high or chronic doses, statins (usually mild and self-limiting), certain antibiotics, antifungals, antiseizure drugs, and a long list of herbal and bodybuilding supplements — green tea extract and anabolic agents are repeat offenders in the DILIN registry.

Viral illness. Hepatitis A, B, C, and E are the classic hits, but even a common systemic viral infection can bump transaminases for a week or two.

Less common but important: hemochromatosis, autoimmune hepatitis, Wilson disease, alpha-1 antitrypsin deficiency, thyroid disease, celiac disease, and biliary obstruction. These usually get worked up when the first retest doesn't normalize.

How clinicians read the pattern — not just the number

A few patterns are worth knowing because they shape what gets ordered next.

• ALT > AST, mild elevation, overweight patient: usually MASLD until worked up.
• AST > ALT, ratio > 2: think alcohol, or non-liver sources like muscle.
• ALT and AST both > 1,000 U/L: acute hepatocellular injury — acetaminophen toxicity, acute viral hepatitis, or ischemic hepatitis. This is urgent.
• ALT/AST up with alkaline phosphatase up more: think biliary, not hepatocellular.
• Isolated AST elevation with normal ALT: check CK and consider a muscle source before chasing the liver.

The single most useful moveFor a mild, unexpected ALT or AST elevation in an otherwise well patient, the most informative next step is often to remove the likely trigger — alcohol, a new supplement, a hard training block — and retest in a few weeks.

When a clinician re-tests — the timing that matters

There's no single universal interval, but the ACG guideline frames it well: the retest window depends on how high the enzymes are and how sick the patient looks.

Mild elevation (under ~2x upper limit), well patient. Standard practice is to repeat in 2 to 6 weeks after addressing modifiable factors — hold alcohol, pause non-essential supplements, avoid heavy exercise in the 48-72 hours before the draw, and review the medication list.

Moderate elevation (2-5x upper limit). A shorter window — often 2 to 4 weeks — plus a broader workup in parallel: hepatitis B and C serologies, iron studies, and imaging if MASLD is suspected.

Marked elevation (>5x upper limit), or any symptoms. This moves out of the routine-retest conversation and into a same-week evaluation, often with imaging and expanded serologies up front.

Persistently elevated at retest. If a mild elevation hasn't resolved after 3-6 months of addressing lifestyle factors, the standard workup expands to autoimmune markers, ceruloplasmin in younger patients, alpha-1 antitrypsin, and often a FibroScan or similar non-invasive fibrosis assessment.

What to actually do before a repeat draw

A few practical notes that improve the signal of the retest:

• Skip hard training for 48-72 hours beforehand. The exercise effect on AST is real and can muddy the picture.
• Be honest with your clinician about alcohol in the preceding week — not for judgment, but because it changes the interpretation.
• Bring a full list of supplements, including anything labeled "natural" or "liver support." A striking fraction of drug-induced liver injury in the DILIN cohort traced to herbal and dietary supplements.
• Don't fast obsessively or dehydrate. Standard lab prep is fine.

A single elevated ALT or AST is a signal, not a diagnosis. The retest is where the real information lives.

The bottom line

Mild ALT and AST elevations are among the most common incidental findings on routine bloodwork, and most of them resolve or get explained with a careful history and a repeat draw a few weeks later. The number itself matters less than the pattern, the trajectory, and the context around it — which is why a clinician's review of your full picture, not just the lab slip, is what turns a flagged value into a plan.

References

1. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology. 2017;112(1):18-35. Source
2. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835. Source
3. Pettersson J, Hindorf U, Persson P, et al. Muscular exercise can cause highly pathological liver function tests in healthy men. British Journal of Clinical Pharmacology. 2008;65(2):253-259. Source
4. Chalasani N, Bonkovsky HL, Fontana R, et al. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015;148(7):1340-1352. Source

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.